Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Mark Galantowicz, MD

Mark Galantowicz, MD

  • Specialty: Pediatric Cardiothoracic Surgery
  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH Rainbow Babies & Children's Hospital (0 mi.)

11100 Euclid Ave
Ste 170
Cleveland, OH 44106

Biography: Mark Galantowicz, MD


  • Co-Director, The Congenital Heart Collaborative, UH Rainbow Babies and Children's Hospital

Certifications & Memberships

  • Congenital Cardiac Surgery - American Board of Thoracic Surgery
  • Thoracic and Cardiac Surgery - American Board of Thoracic Surgery


Fellowship | Pediatric Cardiothoracic Surgery
Pediatric Cardiothoracic Surgery - New York-Presbyterian/Columbia University Medical Center (1995 - 1996)

Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - New York-Presbyterian/Columbia University Medical Center (1993 - 1995)

Residency | General Surgery
General Surgery - New York-Presbyterian/Columbia University Medical Center (1987 - 1993)

Medical Education
Weill Cornell Medical College (1987)

University Of Pennsylvania (1982)


Mark Galantowicz, MD, is the Chief of Cardiothoracic Surgery and Co-Director of The Heart Center at Nationwide Children’s Hospital. Dr. Galantowicz is also a Professor of Surgery at The Ohio State University College of Medicine and is the recipient of the Murray D. Lincoln Endowed Chair in Cardiothoracic Surgery. After receiving his undergraduate degree from the University of Pennsylvania, Dr. Galantowicz was awarded the Fulbright Scholarship to conduct molecular biology research at the University of Geneva, Switzerland. He received his medical degree from Cornell University Medical College and completed his surgical training, including fellowships in adult and pediatric cardiothoracic surgery, at Columbia-Presbyterian Medical Center. He is certified in both Pediatric and Adult Cardiothoracic Surgery.

Dr. Galantowicz joined Nationwide Children’s Hospital in 2002 to head the Department of Cardiothoracic Surgery and where he also serves as the Surgical Director of the Heart, Lung and Heart-Lung Transplantation Programs. His clinical interests are in the areas of the surgical treatment and repair of newborns with congenital heart defects and cardiopulmonary transplantation. In his tenure at Nationwide Children’s he completed the hospital’s first successful heart, lung, and heart-lung transplants including some of the youngest and smallest patients in the world. His work has helped expand the hospital’s Blood Conservation Program for congenital heart surgery, making The Heart Center an international treatment center for patients coming from all over the world. Additionally, he helped design the country’s first Hybrid Congenital Cardiac Operating Suite, allowing the technology first developed in the Hybrid Catheterization Suites to translate into a state-of-the-art operating suite.

His research interests focus on the development of innovative, less-invasive strategies for the management of cardiopulmonary disease. Dr. Galantowicz has authored several publications and presented to both national and international audiences on his surgical and hybrid procedures to treat cardiac malformations and congenital heart disease. His combined talent and expertise extends across borders as he performs life-saving operations on children with heart defects in developing countries.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Mark Galantowicz did not disclose any Outside Relationships with Industry.